| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.6 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.6 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.6 |